Market
BSE Prices delayed by 5 minutes... << Prices as on Sep 04, 2026 - 3:59PM >>  ABB India  7419.9 [ -0.15% ] ACC  1287 [ 1.18% ] Ambuja Cements  405.5 [ 0.57% ] Asian Paints  2527.75 [ -0.48% ] Axis Bank  1273 [ 0.54% ] Bajaj Auto  11920.65 [ -0.79% ] Bank of Baroda  239.2 [ -0.50% ] Bharti Airtel  1842 [ -1.24% ] Bharat Heavy  433.35 [ 0.13% ] Bharat Petroleum  315.7 [ -1.33% ] Britannia Industries  5104 [ -1.85% ] Cipla  1385 [ -0.29% ] Coal India  414.3 [ -1.16% ] Colgate Palm  1836 [ -0.65% ] Dabur India  380.25 [ 0.07% ] DLF  681.2 [ 0.03% ] Dr. Reddy's Lab.  1154 [ -0.09% ] GAIL (India)  173.3 [ -0.35% ] Grasim Industries  3313.2 [ 0.10% ] HCL Technologies  1294 [ -1.24% ] HDFC Bank  713.15 [ 1.30% ] Hero MotoCorp  5303 [ 0.21% ] Hindustan Unilever  1974 [ 0.91% ] Hindalco Industries  1013.8 [ -0.22% ] ICICI Bank  1423 [ -0.14% ] Indian Hotels Co.  718.75 [ -1.81% ] IndusInd Bank  1006 [ 0.50% ] Infosys  1130 [ 0.18% ] ITC  264.1 [ 0.74% ] Jindal Steel  1163 [ 2.24% ] Kotak Mahindra Bank  424.85 [ 1.15% ] L&T  3966 [ 0.03% ] Lupin  2111 [ -1.12% ] Mahi. & Mahi  3168.9 [ 0.92% ] Maruti Suzuki India  12700 [ -0.04% ] MTNL  26.6 [ 0.61% ] Nestle India  1420 [ -0.35% ] NIIT  99.05 [ 1.69% ] NMDC  84.65 [ 0.30% ] NTPC  332.6 [ 0.80% ] ONGC  234.85 [ -0.89% ] Punj. NationlBak  116.8 [ 0.26% ] Power Grid Corpn.  266 [ 0.38% ] Reliance Industries  1322 [ 1.61% ] SBI  1017 [ 0.00% ] Vedanta  272 [ 0.87% ] Shipping Corpn.  295.15 [ -0.02% ] Sun Pharmaceutical  1899 [ -0.26% ] Tata Chemicals  625.35 [ -2.59% ] Tata Consumer  1012 [ -0.94% ] Tata Motors Passenge  312 [ 0.22% ] Tata Steel  189 [ 2.91% ] Tata Power Co.  368 [ 0.82% ] Tata Consult. Serv.  2300.9 [ -0.48% ] Tech Mahindra  1592 [ -0.31% ] UltraTech Cement  11348 [ 1.11% ] United Spirits  1475 [ -0.59% ] Wipro  176.8 [ 0.11% ] Zee Entertainment  91.34 [ -0.28% ] 
Gland Pharma Ltd. Auditor Report
Search Company 
You can view full text of the latest Auditor's Report for the company.
Market Cap. (Rs.) 48374.82 Cr. P/BV 4.53 Book Value (Rs.) 647.10
52 Week High/Low (Rs.) 3040/1574 FV/ML 1/1 P/E(X) 47.09
Bookclosure 11/08/2026 EPS (Rs.) 62.27 Div Yield (%) 0.00
Year End :2026-03 

Sr.

No.

Key Audit Matter

Auditor's Response

1

Revenue from Sale of goods (Refer
note 2.1(f) of the Standalone Financial
Statements)

The Company recognises revenue from sale
of goods based on the terms and conditions
of the agreements/arrangements, which
vary with different customers.

For sale transactions in a certain period
around the Balance Sheet date, it is essential
to ensure whether the transfer of control of
the goods by the Company to the customer
occurs before the Balance Sheet date.

Considering material sale transactions close
to the year end and that revenue recognition
is subject to transfer of control to the
customers before the Balance Sheet date,
we consider the risk of revenue from sale
of goods being recognised in the incorrect
period as a key audit matter.

We have performed the following principal audit procedures in relation

to revenue recognised which include a combination of testing internal

controls and substantive testing as under:

• Assessed the appropriateness of the Company's revenue recognition
accounting policies in line with Ind AS 115 (“Revenue from Contracts
with Customers").

• Evaluated the integrity of the general information and technology ('IT')
control environment and testing the operating effectiveness of key IT
application controls.

• Understood the revenue recognition process, evaluating the design
and implementation of Company's controls in respect of revenue cut¬
off at year-end.

• Tested the operating effectiveness of such controls over revenue cut
off at year-end.

• Tested the supporting documentation for sales transactions recorded
during the period closer to the year end and subsequent to the year
end, including examination of credit notes issued after the year end
to determine whether revenue was recognised in the correct period
upon fulfillment of the performance obligations.

Performed analytical procedures on current year revenue based on
monthly trends and where appropriate, conducting further enquiries
and testing.

Sr.

No.

Key Audit Matter

Auditor's Response

2

Assessment for impairment of Investment

We have performed the following principal audit procedures in relation

in subsidiary:

to assessment of impairment of investment in subsidiary, which include

The Company has investment of '32,925.52

a

combination of testing internal controls and substantive testing as

million in Gland Pharma International Pte.

under:

Ltd., Singapore, a wholly-owned subsidiary,

a.

Obtained an understanding of the management's process for

which is carried at cost. (Refer Note 7 of the

identification of impairment indicators.

Financial Statements)

b.

Evaluated the design and implementation of the relevant controls

The Company assesses the recoverable

and the operating effectiveness of such internal controls which

amounts of investment when impairment

inter-alia includes the completeness and accuracy of the input

indicators exist by using the Value in Use

data considered, reasonableness of the assumptions considered

(ViU) approach.

in determining the present value of future cash flows.

The determination of recoverable amount of

c.

Obtained the business projections (prepared by the Management)

investment based on ViU, involves significant

and performed the following procedures:

estimates and judgement in determining
the assumptions such as revenue growth,
operating margins, and in determining the
valuation assumptions relating to discount
rates and long-term growth rate applied to
estimate future cash flows.

Impairment of investment has been
identified as a key audit matter due to:

(i)

(ii)

(iii)

(iv)

(v)

Conducted inquiries with the Management to identify if
factors that, in our professional judgement, should be taken
into account in the analysis were considered.

Assessed the cash flow forecasts through analysis of actual
past performance and comparison to previous forecasts.

Verified if the cash flow projections used for the assessment
of impairment were reviewed and approved by the Board
of Directors of the Company and that of the step down
subsidiary.

Evaluated the Management's future cash flow projections,
with regard to the appropriateness of key assumptions
considered, including discount rate, growth rate, sensitivity
analysis of the key assumptions etc. duly considering the
historical accuracy of the Company's estimates in the prior
period, and comparison of the assumptions with observable
market data wherever available.

Involved our valuation specialists to review key assumptions

• The significance of the carrying value of
the investment; and

• The assessment of the carrying value
involving assumptions and exercise
of significant judgement in predicting
future cash flow projections. Any
adverse changes to this assumption
could result in lower recoverable

amount than the carrying amount.

considered in the ViU workings such as discount rate and
growth rate.

We have audited the accompanying standalone financial
statements of
Gland Pharma Limited (the “Company"),
which comprise the Balance Sheet as at March 31, 2026,
and the Statement of Profit and Loss (including Other
Comprehensive Income), the Statement of Changes
in Equity and the Statement of Cash Flows for the year
ended on that date, and notes to the financial statements,
including a summary of material accounting policies and
other explanatory information.

In our opinion and to the best of our information and
according to the explanations given to us, the aforesaid
standalone financial statements give the information
required by the Companies Act, 2013 (the “Act") in
the manner so required and give a true and fair view
in conformity with the Indian Accounting Standards
prescribed under Section 133 of the Act, (“Ind AS") and
other accounting principles generally accepted in India, of
the state of affairs of the Company as at March 31, 2026,
its profit and other comprehensive income, its cash flows
and the changes in equity for the year ended on that date.

Basis for Opinion

We conducted our audit of the standalone financial
statements in accordance with the Standards on Auditing
(“SA"s) specified under Section 143(10) of the Act. Our
responsibilities under those Standards are further described
in the Auditor's Responsibility for the Audit of the Standalone
Financial Statements section of our report. We are
independent of the Company in accordance with the Code
of Ethics issued by the Institute of Chartered Accountants
of India (“ICAI") together with the ethical requirements
that are relevant to our audit of the standalone financial
statements under the provisions of the Act and the Rules
made thereunder, and we have fulfilled our other ethical
responsibilities in accordance with these requirements
and the ICAI's Code of Ethics. We believe that the audit
evidence obtained by us is sufficient and appropriate to
provide a basis for our audit opinion on the standalone
financial statements.

Key Audit Matters

Key audit matters are those matters that, in our professional
judgment, were of most significance in our audit of the
standalone financial statements of the current period.
These matters were addressed in the context of our audit
of the standalone financial statements as a whole, and in
forming our opinion thereon, and we do not provide a
separate opinion on these matters. We have determined
the matters described below to be the key audit matters to
be communicated in our report.

Information Other than the Financial Statements
and Auditor's Report Thereon

• The Company's Board of Directors is responsible
for the other information. The other information
comprises the information included in the Directors'
report, Management Discussion & Analysis, Report on
Corporate Governance and the Business Responsibility
& Sustainability Report but, does not include the
consolidated financial statements, standalone financial
statements and our auditor's report thereon.

• Our opinion on the standalone financial statements
does not cover the other information and we do not
express any form of assurance conclusion thereon.

• In connection with our audit of the standalone
financial statements, our responsibility is to read the
other information and, in doing so, consider whether
the other information is materially inconsistent with
the standalone financial statements or our knowledge
obtained during the course of our audit or otherwise
appears to be materially misstated.

• If, based on the work we have performed, we conclude
that there is a material misstatement of this other
information, we are required to report that fact. We
have nothing to report in this regard.

Responsibilities of Management and Board of
Directors for the Standalone Financial Statements

The Company's Board of Directors is responsible for the
matters stated in Section 134(5) of the Act with respect to
the preparation of these standalone financial statements
that give a true and fair view of the financial position, financial
performance including other comprehensive income, cash
flows and changes in equity of the Company in accordance
with the accounting principles generally accepted in India,
including Ind AS specified under Section 133 of the Act.
This responsibility also includes maintenance of adequate
accounting records in accordance with the provisions of
the Act for safeguarding the assets of the Company and for
preventing and detecting frauds and other irregularities;
selection and application of appropriate accounting
policies; making judgments and estimates that are
reasonable and prudent; and design, implementation and

maintenance of adequate internal financial controls, that
were operating effectively for ensuring the accuracy and
completeness of the accounting records, relevant to the
preparation and presentation of the financial statements
that give a true and fair view and are free from material
misstatement, whether due to fraud or error.

In preparing the standalone financial statements,
management and Board of Directors are responsible for
assessing the Company's ability to continue as a going
concern, disclosing, as applicable, matters related to going
concern and using the going concern basis of accounting
unless the Board of Directors either intend to liquidate
the Company or to cease operations, or has no realistic
alternative but to do so.

The Company's Board of Directors is also responsible for
overseeing the Company's financial reporting process.

Auditor's Responsibility for the Audit of the
Standalone Financial Statements

Our objectives are to obtain reasonable assurance about
whether the standalone financial statements as a whole
are free from material misstatement, whether due to fraud
or error, and to issue an auditor's report that includes our
opinion. Reasonable assurance is a high level of assurance,
but is not a guarantee that an audit conducted in accordance
with SAs will always detect a material misstatement when it
exists. Misstatements can arise from fraud or error and are
considered material if, individually or in the aggregate, they
could reasonably be expected to influence the economic
decisions of users taken on the basis of these standalone
financial statements.

As part of an audit in accordance with SAs, we exercise
professional judgment and maintain professional skepticism
throughout the audit. We also:

• Identify and assess the risks of material misstatement
of the standalone financial statements, whether due
to fraud or error, design and perform audit procedures
responsive to those risks, and obtain audit evidence
that is sufficient and appropriate to provide a basis
for our opinion. The risk of not detecting a material
misstatement resulting from fraud is higher than for
one resulting from error, as fraud may involve collusion,
forgery, intentional omissions, misrepresentations, or
the override of internal control.

• Obtain an understanding of internal financial controls
relevant to the audit in order to design audit procedures
that are appropriate in the circumstances. Under
Section 143(3)(i) of the Act, we are also responsible
for expressing our opinion on whether the Company
has adequate internal financial controls with reference
to standalone financial statements in place and the
operating effectiveness of such controls.

• Evaluate the appropriateness of accounting policies
used and the reasonableness of accounting estimates
and related disclosures made by the management.

• Conclude on the appropriateness of management's
use of the going concern basis of accounting and,
based on the audit evidence obtained, whether
a material uncertainty exists related to events or
conditions that may cast significant doubt on the
Company's ability to continue as a going concern.
If we conclude that a material uncertainty exists, we
are required to draw attention in our auditor's report
to the related disclosures in the standalone financial
statements or, if such disclosures are inadequate, to
modify our opinion. Our conclusions are based on
the audit evidence obtained up to the date of our
auditor's report. However, future events or conditions
may cause the Company to cease to continue as a
going concern.

• Evaluate the overall presentation, structure and content
of the standalone financial statements, including the
disclosures, and whether the standalone financial
statements represent the underlying transactions and
events in a manner that achieves fair presentation.

Materiality is the magnitude of misstatements in the
standalone financial statements that, individually or in
aggregate, makes it probable that the economic decisions
of a reasonably knowledgeable user of the standalone
financial statements may be influenced. We consider
quantitative materiality and qualitative factors in (i) planning
the scope of our audit work and in evaluating the results
of our work; and (ii) to evaluate the effect of any identified
misstatements in the standalone financial statements.

We communicate with those charged with governance
regarding, among other matters, the planned scope and
timing of the audit and significant audit findings, including
any significant deficiencies in internal financial controls that
we identify during our audit.

We also provide those charged with governance with
a statement that we have complied with relevant
ethical requirements regarding independence, and to
communicate with them all relationships and other
matters that may reasonably be thought to bear on our
independence, and where applicable, related safeguards.

From the matters communicated with those charged with
governance, we determine those matters that were of
most significance in the audit of the standalone financial
statements of the current period and are therefore the key
audit matters. We describe these matters in our auditor's
report unless law or regulation precludes public disclosure
about the matter or when, in extremely rare circumstances,
we determine that a matter should not be communicated
in our report because the adverse consequences of doing
so would reasonably be expected to outweigh the public
interest benefits of such communication.

Report on Other Legal and Regulatory
Requirements

1. As required by Section 143(3) of the Act, based on our
audit, we report that:

a) We have sought and obtained all the information and
explanations which to the best of our knowledge and
belief were necessary for the purposes of our audit.

b) In our opinion, proper books of account as required
by law have been kept by the Company so far as it
appears from our examination of those books.

c) The Balance Sheet, the Statement of Profit and
Loss including Other Comprehensive Income, the
Statement of Cash Flows and Statement of Changes
in Equity dealt with by this Report are in agreement
with the relevant books of account.

d) In our opinion, the aforesaid standalone financial
statements comply with the Ind AS specified under
Section 133 of the Act.

e) On the basis of the written representations received
from the directors as on March 31, 2026 taken on
record by the Board of Directors, none of the directors
is disqualified as on March 31, 2026 from being
appointed as a director in terms of Section 164(2) of
the Act.

f) With respect to the adequacy of the internal financial
controls with reference to standalone financial
statements of the Company and the operating
effectiveness of such controls, refer to our separate
Report in “
Annexure A". Our report expresses
an unmodified opinion on the adequacy and
operating effectiveness of the Company's internal
financial controls with reference to standalone
financial statements.

g) With respect to the other matters to be included in the
Auditor's Report in accordance with the requirements
of Section 197(16) of the Act, as amended, in our
opinion and to the best of our information and
according to the explanations given to us, the
remuneration paid by the Company to its directors
during the year is in accordance with the provisions
of Section 197 of the Act.

h) With respect to the other matters to be included in
the Auditor's Report in accordance with Rule 11 of
the Companies (Audit and Auditors) Rules, 2014,
as amended in our opinion and to the best of our
information and according to the explanations given
to us:

i. The Company has disclosed the impact of
pending litigations on its financial position in its
standalone financial statements - Refer Note 43b
to the standalone financial statements;

ii. The Company did not have any long-term
contracts including derivative contracts for which
there were any material foreseeable losses.

iii. There were no amounts which were required
to be transferred to the Investor Education and
Protection Fund by the Company.

iv. (a) The Management has represented that,

to the best of its knowledge and belief,
other than as disclosed in the Note 48 to
the standalone financial statements, no
funds have been advanced or loaned or
invested (either from borrowed funds or
share premium or any other sources or
kind of funds) by the Company to or in
any other person(s) or entity(ies), including
foreign entities (“Intermediaries"), with the
understanding, whether recorded in writing
or otherwise, that the Intermediary shall,
directly or indirectly lend or invest in other
persons or entities identified in any manner
whatsoever by or on behalf of the Company
(“Ultimate Beneficiaries") or provide any
guarantee, security or the like on behalf of
the Ultimate Beneficiaries.

(b) The Management has represented, that,
to the best of its knowledge and belief, no
funds have been received by the Company
from any person(s) or entity(ies), including
foreign entities (“Funding Parties"), with the
understanding, whether recorded in writing
or otherwise, that the Company shall,
directly or indirectly, lend or invest in other
persons or entities identified in any manner
whatsoever by or on behalf of the Funding
Party (“Ultimate Beneficiaries") or provide
any guarantee, security or the like on behalf
of the Ultimate Beneficiaries.

(c) Based on the audit procedures performed
that have been considered reasonable and
appropriate in the circumstances, nothing
has come to our notice that has caused us
to believe that the representations under
sub-clause (i) and (ii) of Rule 11(e), as
provided under (a) and (b) above, contain
any material misstatement.

v. The final dividend proposed in the previous year,
declared and paid by the Company during the
year is in accordance with Section 123 of the Act,
as applicable.

As stated in note 16 to the standalone financial
statements, the Board of Directors of the
Company has proposed final dividend for the year
which is subject to the approval of the members

at the ensuing Annual General Meeting. Such
dividend proposed is in accordance with Section
123 of the Act, as applicable.

vi. Based on our examination, which included test
checks, the Company has used accounting
software systems for maintaining its books of
account for the financial year ended March 31,
2026 which have the feature of recording audit
trail (edit log) facility and the same has operated
throughout the year for all relevant transactions
recorded in the software systems. Further,
during the course of our audit we did not come
across any instance of the audit trail feature
being tampered with and the audit trail has been
preserved by the Company as per the statutory
requirements for record retention.

2. As required by the Companies (Auditor's Report) Order,
2020 (“the Order") issued by the Central Government
in terms of Section 143(11) of the Act, we give in
Annexure B" a statement on the matters specified in
paragraphs 3 and 4 of the Order.

For Deloitte Haskins & Sells

Chartered Accountants
(Firm's Registration Number: 008072S)

Monisha Parikh

Partner

Membership No. 047840
UDIN:26047840SEJPAR7523

Place: Seoul
Date: May 15, 2026


 
KYC IS ONE TIME EXERCISE WHILE DEALING IN SECURITIES MARKETS - ONCE KYC IS DONE THROUGH A SEBI REGISTERED INTERMEDIARY (BROKER, DP, MUTUAL FUND ETC.), YOU NEED NOT UNDERGO THE SAME PROCESS AGAIN WHEN YOU APPROACH ANOTHER INTERMEDIARY. | PREVENT UNAUTHORISED TRANSACTIONS IN YOUR ACCOUNT --> UPDATE YOUR MOBILE NUMBERS/EMAIL IDS WITH YOUR STOCK BROKER/DEPOSITORY PARTICIPANT. RECEIVE INFORMATION/ALERT OF YOUR TRANSACTIONS DIRECTLY FROM EXCHANGE/NSDL ON YOUR MOBILE/EMAIL AT THE END OF THE DAY .......... ISSUED IN THE INTEREST OF INVESTORS
Disclaimer Clause | Privacy | Terms of Use | Rules and regulations | Feedback| IG Redressal Mechanism | Investor Charter | Client Bank Accounts
Stocks A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Others
MUTUAL FUND A B C D E F G H I J K L M N O P Q R S T U V W X Y Z OTHERS
Right and Obligation, RDD, Guidance Note in Vernacular Language
Attention Investors : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
  "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
  "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participants. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day.Issued in the interest of Investors."
Regd. Office: 76-77, Scindia House, 1st Floor, Janpath, Connaught Place, New Delhi – 110001
NSE CASH , NSE F&O,NSE CDS| BSE CASH ,BSE CDS |DP NSDL | MCX-SX SEBI NO: INZ000155732

Compliance Officer: Mukesh Rustagi, Company Secretary, Tel: 011-46890000, Email: mukesh_rustagi80@hotmail.com
For grievances please e-mail at: kkslig@hotmail.com

Important Links : NSE | BSE | MCX | SEBI | NSDL | Speed-e | CDSL | SCORES | NSDL E-voting | CDSL E-voting | SMART ODR | ODR CIRCULAR
 
Charts are powered by TradingView.
Copyrights @ 2014 © KK Securities Limited. All Right Reserved
Designed, developed and content provided by